Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms

  • Authors:
    • Laetitia Delort
    • Stéphane Perrier
    • Virginie Dubois
    • Hermine Billard
    • Tomas Mracek
    • Chen Bing
    • Marie-Paule Vasson
    • Florence Caldefie-Chézet
  • View Affiliations

  • Published online on: February 27, 2013     https://doi.org/10.3892/or.2013.2311
  • Pages: 2025-2029
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Zinc-α2-glycoprotein (ZAG) is a new adipokine whose gene expression is downregulated in obese patients. We recently reported ZAG expression in breast tumor or healthy breast tissue and detected this expression at high levels in ductal carcinoma and in normal epithelial adjacent tissue but not in normal tissue of healthy women. In the present study, we used two human breast tumor cell lines (MCF-7 and MDA-MB‑231) and one fibrocystic breast cell line (MCF‑10a) to examine whether recombinant ZAG has an effect on proliferative/apoptotic response in breast cancer cell lines. ZAG seemed to exert a proliferative effect on breast cancer cell proliferation [+11 to 27% in MCF-7 with (ZAG) = 5-20 µg/ml; +13% in MDA-MB-231 with (ZAG) = 5 µg/ml] and, on the contrary, an anti-proliferative effect in the fibrocystic breast cell line [-5 to -8% in MCF-10a with (ZAG) = 5-10 µg/ml]. ZAG was able to modulate gene and protein expression involved in the apoptotic response. However, further studies are required to fully elucidate the effects of ZAG on the proliferation of mammary cells.
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 29 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Delort L, Perrier S, Dubois V, Billard H, Mracek T, Bing C, Vasson M and Caldefie-Chézet F: Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms. Oncol Rep 29: 2025-2029, 2013.
APA
Delort, L., Perrier, S., Dubois, V., Billard, H., Mracek, T., Bing, C. ... Caldefie-Chézet, F. (2013). Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms. Oncology Reports, 29, 2025-2029. https://doi.org/10.3892/or.2013.2311
MLA
Delort, L., Perrier, S., Dubois, V., Billard, H., Mracek, T., Bing, C., Vasson, M., Caldefie-Chézet, F."Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms". Oncology Reports 29.5 (2013): 2025-2029.
Chicago
Delort, L., Perrier, S., Dubois, V., Billard, H., Mracek, T., Bing, C., Vasson, M., Caldefie-Chézet, F."Zinc-α2-glycoprotein: A proliferative factor for breast cancer? In vitro study and molecular mechanisms". Oncology Reports 29, no. 5 (2013): 2025-2029. https://doi.org/10.3892/or.2013.2311